학술논문

Adverse Change in Employment Status After Acute Myocardial Infarction
Document Type
article
Source
Circulation Cardiovascular Quality and Outcomes. 11(6)
Subject
Health Services and Systems
Biomedical and Clinical Sciences
Clinical Sciences
Health Sciences
Behavioral and Social Science
Clinical Research
Heart Disease - Coronary Heart Disease
Heart Disease
Depression
Mental Health
Patient Safety
Cardiovascular
Good Health and Well Being
Absenteeism
Acute Coronary Syndrome
Aged
Cost of Illness
Drug Costs
Employment
Female
Health Expenditures
Health Status
Humans
Longitudinal Studies
Male
Medication Adherence
Middle Aged
Myocardial Infarction
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Quality of Life
Registries
Retirement
Return to Work
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Unemployment
United States
depression
employment
medication
adherence
myocardial infarction
quality of life
Cardiorespiratory Medicine and Haematology
Public Health and Health Services
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Public health
Language
Abstract
BACKGROUND:Inability to resume employment after acute myocardial infarction (MI) has important implications for patients. We sought to assess the prevalence of and outcomes associated with adverse change in employment after MI in a national US cohort. METHODS AND RESULTS:The TRANSLATE-ACS study (Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome) assessed employment status at baseline and 1 year among 9319 patients with MI (mean age, 60.8 years; SD, 11.3; 27.3% women) enrolled at 233 US hospitals. We defined adverse change in employment as patients working at baseline but working less or not working at 1-year post-MI. In multivariable models, we assessed factors associated with adverse change in employment and its association with patient-reported depression, health status, persistence to evidence-based medications prescribed at discharge, and financial hardship affording medications. Half of the patients (51%; n=4730) were employed at the time of MI. By 1 year, 10% (n=492) of these reported an adverse change in employment, with 3% (n=143) working less and 7% (n=349) no longer working (only 27 of 349 reported retirement). Factors significantly associated with adverse change in employment included a number of unplanned readmissions, postdischarge bleeding complications, hypertension, and smoking. At 1 year, patients with an adverse change in employment were more likely to report depression (Patient Health Questionnaire 2 score >3: 27.4% versus 16.7%), lower health status (mean EuroQoL visual analogue scale: 73 [SD, 17.8] versus 78 [SD, 14.8]), and moderate-extreme financial hardship with medication costs (41.0% versus 28.4%; all P